Moloney Securities Asset Management LLC Acquires 14,245 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Moloney Securities Asset Management LLC lifted its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 53.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 40,732 shares of the company's stock after buying an additional 14,245 shares during the period. Moloney Securities Asset Management LLC's holdings in Roche were worth $1,672,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Altrius Capital Management Inc boosted its stake in Roche by 3.6% during the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock valued at $7,818,000 after purchasing an additional 6,545 shares during the period. Hancock Whitney Corp boosted its stake in Roche by 6.8% during the 4th quarter. Hancock Whitney Corp now owns 23,516 shares of the company's stock valued at $820,000 after purchasing an additional 1,496 shares during the period. Bard Financial Services Inc. boosted its stake in Roche by 25.3% during the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock valued at $5,716,000 after purchasing an additional 28,050 shares during the period. Rhumbline Advisers boosted its stake in Roche by 7.4% during the 1st quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock valued at $4,413,000 after purchasing an additional 7,374 shares during the period. Finally, GAMMA Investing LLC boosted its stake in Roche by 59.5% during the 1st quarter. GAMMA Investing LLC now owns 12,850 shares of the company's stock valued at $529,000 after purchasing an additional 4,794 shares during the period.

Roche Stock Down 1.8%

Shares of RHHBY stock traded down $0.73 during trading hours on Friday, reaching $40.49. 1,941,801 shares of the stock traded hands, compared to its average volume of 1,088,582. Roche Holding AG has a 1-year low of $34.10 and a 1-year high of $44.31. The business has a fifty day moving average price of $40.12 and a 200 day moving average price of $39.73. The company has a quick ratio of 1.20, a current ratio of 1.48 and a debt-to-equity ratio of 0.85.

Wall Street Analysts Forecast Growth

RHHBY has been the subject of a number of research analyst reports. Hsbc Global Res lowered shares of Roche from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 28th. HSBC lowered shares of Roche from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy".

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.